Cibus (CBUS) EBT (2016 - 2026)
Cibus (CBUS) posted EBT of -$31.9 million for Q4 2025, down 31.4% sequentially from -$24.3 million in Q3 2025, and down 23.82% YoY from -$41.9 million in Q4 2024.
Cibus (CBUS) EBT (2016 - 2026) Analysis & Trends
Cibus has reported EBT for 10 years, with the latest figure at -$31.9 million in Q4 2025.
- Quarterly EBT fell 23.82% year-over-year to -$31.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$132.2 million (up 53.24% YoY) and the FY2025 annual result came in at -$132.2 million, up 53.24% from the prior year.
- EBT slipped to -$31.9 million in Q4 2025 per CBUS's latest filing, from -$24.3 million in the prior quarter.
- Over five years, EBT peaked at -$2.5 million in Q2 2022 and troughed at -$277.2 million in Q4 2023.
- A 5-year average of -$39.9 million and a median of -$22.4 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2024: EBT slumped 9671.31% in 2023, then surged 90.69% in 2024.
- Over 5 years, EBT stood at -$7.1 million in 2021, then soared by 59.8% to -$2.8 million in 2022, then plunged by 9671.31% to -$277.2 million in 2023, then soared by 90.69% to -$25.8 million in 2024, then slipped by 23.82% to -$31.9 million in 2025.
- According to Business Quant data, EBT over the past three periods registered -$31.9 million, -$24.3 million, and -$26.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | -22.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.14 Mn |
| Dec 31, 2025 | -31.94 Mn |
| Sep 30, 2025 | -24.31 Mn |
| Jun 30, 2025 | -26.53 Mn |
| Mar 31, 2025 | -49.39 Mn |
| Dec 31, 2024 | -25.80 Mn |
| Sep 30, 2024 | -201.45 Mn |
| Jun 30, 2024 | -28.48 Mn |
| Mar 31, 2024 | -26.96 Mn |
| Dec 31, 2023 | -277.21 Mn |
| Sep 30, 2023 | -34.53 Mn |
| Jun 30, 2023 | -20.51 Mn |
| Mar 31, 2023 | -5.39 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -5.95 Mn |
| Jun 30, 2022 | -2.49 Mn |
| Mar 31, 2022 | -5.62 Mn |
| Dec 31, 2021 | -7.06 Mn |
| Sep 30, 2021 | -7.31 Mn |
| Jun 30, 2021 | -4.81 Mn |